NIH partners with industry to find best biological targets of disease
February 17th 2014The National Institutes of Health, FDA, 10 biopharmaceutical companies, the Pharmaceutical Research and Manufacturers of America, and several nonprofit organizations have launched an unprecedented public/private partnership to transform the current model for identifying and validating the most promising biological targets of disease for new diagnostics and drug development.
Survey: Saline shortages affecting 3 out of 4 hospitals
February 12th 2014Saline shortages are affecting three out of four hospitals and healthcare facilities throughout the country, with nearly 30% of these facilities not having adequate supplies to meet patient needs, according to a survey by the American Society of Health-System Pharmacists.
Delirium in critically ill patients can be reduced with statins
January 21st 2014Continued use of statins may help prevent delirium in critically ill patients who received statins before hospital admission, according to a study published online ahead of print in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Antibiotics overused for adult emergency-room patients
January 20th 2014An analysis of emergency department (ED) visits over a 10-year period found that while inappropriate antibiotic use is decreasing in pediatric settings, it continues to remain a problem in adults, according to a study published ahead of print in Antimicrobial Agents and Chemotherapy.
First once-daily dual bronchodilator for COPD approved
December 20th 2013FDA approved umeclidinium and vilanterol inhalation powder (Anoro Ellipta, GlaxoSmithKline and Theravance) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.